THE BEST SIDE OF HEMGENIX

Range of eligible patients: CDEC discussed the uncertainty in the number of patients with reasonably intense to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific industry experts consulted by CADTH indicated that some clients that are categorized as getting mild or average ailment could possibly have a significant bl